Yutaka Niihara - 10 Jun 2021 Form 4 Insider Report for Emmaus Life Sciences, Inc. (EMMA)

Signature
Yutaka Niihara, M.D., M.P.H.
Issuer symbol
EMMA
Transactions as of
10 Jun 2021
Net transactions value
+$5,180
Form type
4
Filing time
14 Jun 2021, 20:02:15 UTC
Previous filing
09 Jun 2021
Next filing
17 Jun 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EMMA Common stock, $0.001 par value Purchase $1,650 +1,000 +0.01% $1.65* 10,758,915 10 Jun 2021 Direct F1
transaction EMMA Common stock, $0.001 par value Purchase $1,264 +800 +0.01% $1.58* 10,759,715 11 Jun 2021 Direct F1, F2
transaction EMMA Common stock, $0.001 par value Purchase $2,266 +1,416 +0.01% $1.60* 10,761,131 14 Jun 2021 Direct F1, F3
holding EMMA Common stock, $0.001 par value 92,794 10 Jun 2021 By Hope International Hospice, Inc. F4
holding EMMA Common stock, $0.001 par value 63,000 10 Jun 2021 By Soomi Niihara
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.
F2 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.55 to $1.59, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) and in footnote (3) to this Form 4.
F3 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.59 to $1.60, inclusive.
F4 Hope International Hospice, Inc, is a California corporation of which Dr. Niihara and his wife are the sole shareholders and directors.